In a landmark medical feat, Cleveland Clinic Abu Dhabi has conducted the UAE’s first robotic cytoreductive surgery, removing a rare and aggressive abdominal tumor. It is a milestone in the nation’s medical history, marking a quantum leap in cancer treatment technology and precision surgery.
The complex procedure entailed surgical removal of multiple cancerous organs, using sophisticated robotic systems that enable unmatched surgical precision. After the cytoreduction surgery, the patient underwent Hyperthermic Intraperitoneal Chemotherapy (HIPEC)—a technique where heated chemotherapy solution is infused directly into the abdominal cavity to kill microscopic cancer cells and minimize recurrence risk.
This two-pronged combination of robotic surgery and HIPEC has only been offered at specialized international institutions in the past. With the introduction of this state-of-the-art treatment to the UAE, Cleveland Clinic Abu Dhabi is providing new hope for patients who would otherwise have had to seek it abroad. The operation also necessitated smooth coordination among oncology, surgical, and robotic specialists—demonstrating the hospital’s multidisciplinary capability.
According to the clinic, the surgery was a success, and the patient is recovering well. This medical feat is not just a personal victory but a national stride towards advanced, localized cancer care, reinforcing Cleveland Clinic Abu Dhabi’s position as a regional leader in complex surgical innovation.
